Home/Investors/Eshelman Ventures

Eshelman Ventures

Biotech Investor · 2 portfolio companies

Portfolio

Focus Areas

Top Stage

Pre-clinical

Investment Focus

Company	Stage	Valuation	Focus
Dignify Therapeutics	Pre-clinical	—	Urology, Gastroenterology
Paradigm Therapeutics	Phase 3	—	Rare Genetic Diseases, Dermatology